Home > Insider Trading > Filing (0001388658-20-000240)

Filing Details

Accession Number:: 0001388658-20-000240
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-02 19:47:05
Reporting Period:: 2020-08-31

Accepted Time:: 2020-09-02 19:47:05
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1388658	Irhythm Technologies Inc.	IRTC	Surgical & Medical Instruments & Apparatus (3841)	208149544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1670676	A David Vort	C/O Irhythm Technologies, Inc. 699 8Th St #600 San Francisco CA 94103	Evp, Sales	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-08-31	5,264	$8.18	21,267	No	4	M	Direct
Common Stock	Disposition	2020-08-31	2,100	$215.00	19,167	No	4	S	Direct
Common Stock	Disposition	2020-08-31	600	$216.24	18,567	No	4	S	Direct
Common Stock	Disposition	2020-08-31	1,221	$217.74	17,346	No	4	S	Direct
Common Stock	Disposition	2020-08-31	653	$218.80	16,693	No	4	S	Direct
Common Stock	Disposition	2020-08-31	46	$220.63	16,647	No	4	S	Direct
Common Stock	Disposition	2020-08-31	644	$223.46	16,003	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2020-08-31	5,264	$0.00	5,264	$8.18

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,543	2019-12-15	2025-12-15	No	4	M	Direct

Footnotes

The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2020.
This transaction was executed in multiple trades at prices ranging from $214.71 to $215.29 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple trades at prices ranging from $217.69 to $218.27 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple trades at prices ranging from $218.77 to $218.97 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This transaction was executed in multiple trades at prices ranging from $222.98 to $223.49 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
This option is fully vested and exercisable in full.